Clinical Trials Directory

Trials / Unknown

UnknownNCT02762136

Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)

Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
216 (estimated)
Sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Functional dyspepsia (FD), which is one of the most common gastrointestinal disorders with high disease burden. Postprandial distress syndrome (PDS) is a common subtype of FD. Although the effectiveness of Chinese herbal formula of Xiang-sha-liu-jun granule (XSLJG) for alleviating PDS symptoms has been assessed in previous studies, more convinced evidence of randomized placebo-controlled study is needed.

Conditions

Interventions

TypeNameDescription
DRUGplacebo
DRUGXiang-sha-liu-jun granulesThe Xiang-sha-liu-jun granules comprises 10 herbs, Astragalus membranaceus (Huangqi) 15g, Codonopsis pilosula (Dangshen) 15 g, fructus aurantii (Zhiqiao) 15g, fructus amomi(Sharen) etc

Timeline

Start date
2015-08-01
Primary completion
2017-12-01
Completion
2018-04-01
First posted
2016-05-04
Last updated
2016-05-05

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02762136. Inclusion in this directory is not an endorsement.